In patients with undifferentiated arthritis, early treatment with baricitinib is linked to a greater 3-month improvement in disease activity than symptomatic treatment with NSAIDs.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/baricitinib-may-offer-short-term-benefits-early-2026a1000ioi?src=rss
Author :
Publish date : 2026-06-08 12:00:00
Copyright for syndicated content belongs to the linked Source.